Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 141938, 10 pages
http://dx.doi.org/10.1155/2014/141938
Research Article

Traditional Formula, Modern Application: Chinese Medicine Formula Sini Tang Improves Early Ventricular Remodeling and Cardiac Function after Myocardial Infarction in Rats

1Center of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
2Molecular Research in Traditional Chinese Medicine Group, Department of Pathophysiology and Allergy Research, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
3Clinical Division of Cardiology, Department of Internal Medicine II, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria

Received 10 February 2014; Accepted 26 April 2014; Published 25 May 2014

Academic Editor: Xingjiang Xiong

Copyright © 2014 Jiangang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Steg, S. K. James, D. Atar et al., “ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar
  2. Z. Yao, “Comparison of individual components of Si Ni Tang formula: effects on raising blood pressure, myocardial infarction and anti schock functions,” Chinese Herb Medicine Research, vol. 2, article 26, 1983. View at Google Scholar
  3. I. Laitinen, J. Notni, K. Pohle et al., “Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction,” EJNMMI Research, vol. 3, article 38, 2013. View at Publisher · View at Google Scholar
  4. M. A. Pfeffer and E. Braunwald, “Ventricular remodeling after myocardial infarction: experimental observations and clinical implications,” Circulation, vol. 81, pp. 1161–1172, 1990. View at Google Scholar · View at Scopus
  5. J. N. Cohn, R. Ferrari, and N. Sharpe, “Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling,” Journal of the American College of Cardiology, vol. 35, no. 3, pp. 569–582, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. He, Y. Wu, M. Jiang, R. Cheng, and R. Shen, “Observation by color Doppler ultrasound on endothelium-dependent dilation of congestive heart failure treated with Kanli decoction,” Zhong Xi Yi Jie He Xue Bao, vol. 2, pp. 268–270, 2004. View at Google Scholar · View at Scopus
  7. G. Li, W. Qi, and K. Xiong, “Clinical observation on 51 patients of acute myocardial infarction treated with thrombolytic therapy combined with Chinese herbal medicine,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, vol. 19, pp. 461–462, 1999. View at Google Scholar · View at Scopus
  8. J. Tian, “Observation of treatment on 105 acute myocardial infarction patients using Si Ni Tang,” Tian Jin Medical Reports, vol. 11, pp. 16–20, 1972. View at Google Scholar
  9. Z. T. Wang, S. R. Wang, and M. J. Zhao, “Comparative study on effect of recipe for activating blood circulation and replenishing Qi on left ventricular remodeling in rats with left heart failure after myocardial infarction,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazh, vol. 22, pp. 376–378, 2002. View at Google Scholar · View at Scopus
  10. Y. F. Li, F. F. Cao, F. Liu, X. Y. Bai, and Y. Lu, “Effects of Shexiangbaoxin pills on the expression of cardiac α1- and β-adrenergic receptor subtypes in rat hearts with heart failure induced by myocardial infarction,” Chinese Medical Journal, vol. 125, no. 9, pp. 1556–1562, 2012. View at Publisher · View at Google Scholar
  11. J. Luo and H. Xu, “Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 927392, 9 pages, 2012. View at Publisher · View at Google Scholar
  12. Z. Zhang, Shang Han Lun (Discussion of Cold-Induced Disorders) 150-219 A.D, China: Public Health Press, 2005.
  13. L. Chuang, “Effects of a Chinese herbal formula, “Si Ni Tang” on myocardial infarction,” Clinical Pharmacology Therapy, vol. 41, pp. 496–501, 1987. View at Google Scholar
  14. F. Qea, Science of Prescriptions, A Newly Compiled Practical English-Chinese Library of Traditional Chinese Medicine, Publishing House of Shanghai University of Traditional Chinese Medicine, 2002.
  15. Y. Liu, W. K. Wu, C. Chen, and X. F. Duan, “Effect of delayed preconditioning induced by Sini decoction on myocardial cell apoptosis and its mitochondrial mechanism,” Zhongguo Zhong Yao Za Zhi, vol. 31, pp. 1269–1272, 2006. View at Google Scholar · View at Scopus
  16. G. Tan, W. Liao, X. Dong et al., “Metabonomic profiles delineate the effect of traditional Chinese medicine Sini decoction on myocardial infarction in rats,” PLoS ONE, vol. 7, no. 4, Article ID e34157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Peter, J. Schinnerl, S. Felsinger et al., “A novel concept for detoxification: complexation between aconitine and liquiritin in a Chinese herbal formula (‘Sini Tang’),” Journal of Ethnopharmacology, vol. 149, no. 2, pp. 562–569, 2013. View at Publisher · View at Google Scholar
  18. J. M. Pfeffer, M. A. Pfeffer, and E. Braunwald, “Influence of chronic captopril therapy on the infarcted left ventricle of the rat,” Circulation Research, vol. 57, no. 1, pp. 84–95, 1985. View at Google Scholar · View at Scopus
  19. H. J. Yin, Y. Zhang, and Y. R. Jiang, “Effect of folium panax quinquefolium saponins on apoptosis of cardiac muscle cells and apoptosis-related gene expression in rats with acute myocardial infarction,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, vol. 25, no. 3, pp. 232–235, 2005. View at Google Scholar · View at Scopus
  20. C.-L. Wang, D.-Z. Shi, H.-J. Yin, and K.-J. Chen, “Effect of panax quinquefolius saponin on angiogenesis and expressions of VEGF and bFGF in myocardium of rats with acute myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 21, pp. 331–334, 2007. View at Google Scholar · View at Scopus
  21. F. Arslan, M. B. Smeets, L. A. J. O'Neill et al., “Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody,” Circulation, vol. 121, no. 1, pp. 80–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Gajarsa and R. A. Kloner, “Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities,” Heart Failure Reviews, vol. 16, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Almendral, V. Shick, C. Rosendorff, and S. A. Atlas, “Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patients,” Journal of the American Society of Hypertension, vol. 4, no. 3, pp. 135–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Devaux, M. Bousquenaud, S. Rodius et al., “Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction,” BMC Medical Genomics, vol. 4, article 83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. N. G. Yousif and F. G. Al-Amran, “Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice,” BMC Cardiovascular Disorders, vol. 11, article 62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Resources IoLA, Guide For the Care and Use of Laboratory Animals, Commission on Life Sciences, National Research Council. National Academy Press, Washington, DC, USA, 1996.
  27. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the arrive guidelines for reporting animal research,” PLoS Biology, vol. 8, no. 6, Article ID e1000412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. “General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine,” WHO/EDM/TRM/, 2000, http://apps.who.int/medicinedocs/en/d/Jwhozip42e/1.html.
  29. J. M. Pfeffer, M. A. Pfeffer, P. J. Fletcher, and E. Braunwald, “Ventricular performance in rats with myocardial infarction and failure,” The American Journal of Medicine, vol. 76, pp. 99–103, 1984. View at Google Scholar · View at Scopus
  30. T. M. Kolettis, M. Barton, D. Langleben, and Y. Matsumura, “Endothelin in coronary artery disease and myocardial infarction,” Cardiology in Review, vol. 21, no. 5, pp. 249–256, 2013. View at Publisher · View at Google Scholar
  31. C. Borghi, P. Marino, P. Zardini, B. Magnani, S. Collatina, and E. Ambrosioni, “Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party,” The American Heart Journal, vol. 136, no. 2, pp. 213–225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Koren, R. B. Devereux, P. N. Casale, D. D. Savage, and J. H. Lragah, “Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension,” Annals of Internal Medicine, vol. 114, no. 5, pp. 345–352, 1991. View at Google Scholar · View at Scopus
  33. A. M. Wu, M. J. Zhao, and D. M. Zhang, “Characteristics of TCM syndrome and appraisal with echocardiography in heart failure rats after myocardial infarction,” Journal of Chinese Integrative Medicine, vol. 27, no. 3, pp. 227–232, 2007. View at Google Scholar · View at Scopus
  34. J. Takagawa, Y. Zhang, M. L. Wong et al., “Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area-and length-based approaches,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2104–2111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Panteghini, “Role and importance of biochemical markers in clinical cardiology,” European Heart Journal, vol. 25, no. 14, pp. 1187–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Sato, H. Fujiwara, and Y. Takatsu, “Biochemical markers in heart failure,” Journal of Cardiology, vol. 59, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Wang, A. Zhang, H. Sun, and P. Wang, “Systems biology technologies enable personalized traditional Chinese medicine: a systematic review,” The American Journal of Chinese Medicine, vol. 40, pp. 1109–1122, 2012. View at Publisher · View at Google Scholar
  38. A. Zhang, H. Sun, P. Wang, Y. Han, and X. Wang, “Future perspectives of personalized medicine in traditional Chinese medicine: systems biology approach,” Complementary Therapies in Medicine, vol. 20, no. 1-2, pp. 93–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Wu, J. Zhai, D. Zhang et al., “Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 967986, 10 pages, 2013. View at Publisher · View at Google Scholar
  40. M. G. Sutton and N. Sharpe, “Left ventricular remodeling after myocardial infarction: pathophysiology and therapy,” Circulation, vol. 101, no. 25, pp. 2981–2988, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. B. R. Cowan and A. A. Young, “Regional analysis of left ventricular motion after myocardial infarction,” in Proceedings of the 6th International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition, vol. 2, p. 884, Sydney, Australia, April 1998.
  42. A. Evangelista, F. Flachskampf, P. Lancellotti et al., “European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies,” European Journal of Echocardiography, vol. 9, no. 4, pp. 438–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Whittaker, D. R. Boughner, and R. A. Kloner, “Role of collagen in acute myocardial infarct expansion,” Circulation, vol. 84, no. 5, pp. 2123–2134, 1991. View at Google Scholar · View at Scopus
  44. J. Dabek, A. Kulach, B. Monastyrska-Cup, and Z. Gasior, “Transforming growth factor beta and cardiovascular diseases: the other facet of the ‘protective cytokine’,” Pharmacological Reports, vol. 58, no. 6, pp. 799–805, 2006. View at Google Scholar · View at Scopus
  45. A. V. Villar, M. Cobo, M. Llano et al., “Plasma levels of transforming growth factor-β1 reflect left ventricular remodeling in aortic stenosis,” PLoS ONE, vol. 4, no. 12, Article ID e8476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. H. Boyd, S. Mathur, Y. Wang, R. M. Bateman, and K. R. Walley, “Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response,” Cardiovascular Research, vol. 72, no. 3, pp. 384–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Favre, P. Musette, V. Douin-Echinard et al., “Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 1064–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. I. Oyama, C. Blais, X. Liu et al., “Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice,” Circulation, vol. 109, no. 6, pp. 784–789, 2004. View at Publisher · View at Google Scholar · View at Scopus